Hydration Pharmaceuticals Co Ltd Fully Paid Ord. Shrs (HPC) Stock Price & News

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	473.07K	473.07K	601.52K	601.52K
Cost of goods sold	167.75K	167.75K	394.05K	394.05K
Cost of revenue	167.75K	167.75K	394.05K	394.05K
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1.05M	1.05M	822.73K	822.73K
Operating expense	1.05M	1.05M	822.73K	822.73K
Total operating expenses	1.21M	1.21M	1.22M	1.22M
Operating income	-740.27K	-740.27K	-615.26K	-615.26K
Other non operating income	32.93K	32.93K	86.32K	86.32K
EBT including unusual items	-710.88K	-710.88K	-528.57K	-528.57K
EBT excluding unusual items	-710.88K	-710.88K	-528.57K	-528.57K
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-711.08K	-711.08K	-528.57K	-528.57K
Net profit margin	-150.31%	-150.31%	-87.87%	-87.87%
Earnings per share	-	-	-	-
Interest and investment income	-	-	-	-
Interest expense	-36.00	-36.00	-	-
Net interest expenses	-36.00	-36.00	-	-
Depreciation and amortization charges	-	-	-	-
EBITDA	-	-	-	-
Gain or loss from assets sale	-	-	-	-

Finance